The Impact Of Work On The Ageing Adult

Document Sample
The Impact Of Work On The Ageing Adult Powered By Docstoc
					New Directions in EH&S Practice

        California Industrial Hygiene Council
               20th Annual Conference

                    6 December 2010
                  San Diego, California




                        John Howard
   National Institute for Occupational Safety and Health
     U.S. Department of Health and Human Services
                      Washington, D.C.
             Some Issues for 2011
• Disaster Responses and Their Long Tail
  – How can you tell when response is really over?
• Influenza and Respiratory Protection
  – What are the relative transmission frequencies?
• Genome v. Exposome
  – Which can give best us the answer to prevent disease?
• Worsening Workforce Health
  – What are the safety and health implications?
           NIOSH Activities

 Rostering

 Health Hazard Evaluations

 Guidance

   OSHA-NIOSH Interim Guidance

 Health Surveillance

 Toxicity Testing
     Deepwater Horizon Response Worker Rostering




Paper & Electronic Records   Targeted Workers                Percentage
        As of 9-6-10                              Male          81%
                                 BP Staff
 Total Collected:   52,429                       Female         19%
                              BP Contractors
                                Volunteers        Asian         2%
                                                Hispanic        9%
                                 Federal
                                                  Black         38%
                              State & Local
                                                All Others      52%
     Exposure Model for HHEs

• On the Water
  – Source Control
  – Burning
  – Booming and Skimming
• On the Land
  – Shore and marsh cleanup
  – Decontamination
  – Waste Stream Management
Beach Cleanup: “Tarpatties”
            HHE: Air Sampling Results
• 2,577 air sample points were collected
   – 840 (33%) PBZ sample points
   – 1,737 (67%) area sample points
• PBZ conducted on 69 individuals on 15 vessels & at 2 ports
   – Only 1 (0.1%) of the 840 personal breathing zone sample points
     exceeded any occupational exposure limit


                              Personal
                              Breathing   General    Total
                                Zone       Area     Samples
     Booming                      46       150        196
     Decontamination             249        12        261
     Dispersant application      123       856        979
     In-situ burning              59       575        634
     Skimming                     81       100        181
     Work at the source          282        44        326
PBZ Results above Minimum Quantifiable Concentration
                                                                                                          Maximum Personal
                                                                             Lowest OEL*
   Compound                                         OSHA PEL                                            Breathing Zone Sample
                                                                              (Country)
                                                                                                                 Point
   2-Butoxyethanol                                    50 ppm               2 ppm (France)                        0.28 ppm
   Anthracene                                           N/A†                     N/A                          0.0029 mg/m3
   Benzene                                             1 ppm                0.1 ppm (US)                       0.0059 ppm
   Carbon monoxide (ceiling)                            N/A                 200 ppm (US)                         220 ppm
   Carbon monoxide                                    50 ppm                 20 ppm (EU)                           3 ppm
   Chrysene                                             N/A                      N/A                           0.011 mg/m3
   Dipropylene glycol butyl ether                       N/A                      N/A                            0.063 ppm
   Ethyl benzene                                     100 ppm               20 ppm (France)                     0.0086 ppm
   Fluoranthracene                                      N/A                      N/A                         0.00014 mg/m3
   Fluorene                                             N/A                      N/A                         0.001 mg/m3‡
                                                                         20 ppm (Germany &
   Limonene                                             N/A                                                     0.085 ppm
                                                                             Switzerland)
   Naphthalene                                        10 ppm             10 ppm (all reported)                   0.11 ppm
   Phenanthrene                                         N/A                      N/A                          0.012 mg/m3
   Propylene glycol                                     N/A                      N/A                           0.17 mg/m3
   Pyrene                                               N/A                      N/A                          0.0041 mg/m3
   Toluene                                           200 ppm                20 ppm (Japan)                      0.074 ppm
   Total hydrocarbons                                   N/A                      N/A                            9.1 mg/m3
   Total PAHs                                           N/A                      N/A                          0.020 mg/m3
   Total particulates                                15 mg/m3             10 mg/m3 (Canada)                    0.18 mg/m3
   Xylene                                            100 ppm              25 ppm (Denmark)                      0.046 ppm
   *Lowest OEL listed in the German Institute for Occupational Safety and Health database of international OELs (available at
   www.dguv.de/bgia/en/gestis/limit_values/index.jsp updated August 2010)
     10
   †N/A = not applicable
   ‡Concentration is between the minimum detectable concentration and the minimum quantifiable concentration
Dispersant Use
         Dispersants: Purposes
– Enhance amount of oil that physically mixes into
  the water column:
   • Reduces risk that oil will contaminate
     shoreline habitats or to come into contact with
     fish, birds and sea mammals
   • Increases exposure of water-column and
     benthic biota to spilled oil
   • Use represents a trade-off decision to
     increase the hydrocarbon load on the water
     column while reducing it on the coastal
     wetland
           Dispersant Composition: Corexit
                       9500A
•    Petroleum distillates (30% by volume)
•    Prophylene glycol (1,2 propandiol)
•    Organic sulfonic acid salt
•    Butanedioic acid
•    Sorbitans
•    2-Propanol, 1-(2-butoxy-1-methylethoxy)
•    2-Butoxyethanol
         – Causes hemolysis, kidney and liver toxicity
         – Found in Corexit 9527 in worrisome concentrations
         – Use discontinued early in spill because of toxicity




    13
Dispersants: Surface, Subsea & Aerial




14
  NIOSH DWH Toxicity Testing
 Acute animal testing (rats):
   Dispersant (Nalco Corexit 9500A)
   Crude Oil from the source (sample from well head
    obtained May 23rd)
   Dispersant/crude oil mixture

 Inhalation studies:
   Measuring pulmonary, cardiovascular, and CNS
    outcomes

 Dermal studies:
   Assessing hypersensitivity and immune-mediated
    responses
                                 Original Article
  Lung Function in Rescue Workers at the World
           Trade Center after 7 Years


Thomas K. Aldrich, M.D., Jackson Gustave, M.P.H., Charles B. Hall, Ph.D., Hillel W.
  Cohen, Dr.P.H., Mayris P. Webber, Dr.P.H., Rachel Zeig-Owens, M.P.H., Kaitlyn
Cosenza, B.A., Vasilios Christodoulou, B.A., Lara Glass, M.P.H., Fairouz Al-Othman,
 M.D., Michael D. Weiden, M.D., Kerry J. Kelly, M.D., and David J. Prezant, M.D.




                                 N Engl J Med
                            Volume 362(14):1263-1272
                                  April 8, 2010
           Principal Findings

• Lung function was measured in firefighters
  and EMS workers who responded to the
  collapse of the World Trade Center towers
  in New York on September 11, 2001
• There was initial marked loss in lung-
  function measures in a substantial
  minority of study subjects without
  substantial recovery during the following 7
  years.
             2. Influenza
• Is the word “pandemic” counterproductive?
• H5N1 Influenza – Is it coming?
• What is the relative contribution of droplets
  vs. aerosols in influenza transmission?
• What is current CDC Guidance?
• Should CDC Guidance become an OSHA
  standard?
• Should vaccination be mandatory for
  healthcare providers?
What Does “Pandemic” Mean?
      » Indicates the extent of geographical
        spread around the world

      » Does not mean pathogenicity or
        virulence

      » WHO declared pandemic level 6 in June
        2009

      » Concept of geographical spread versus
        severity is confusing to the media and to
        the public
      “Expected” Avian Influenza (H5N1)
• In 1997, influenza A viruses of H5N1 subtype first isolated from a
  patient in Hong Kong

• Highly contagious and deadly pathogen in poultry and has reached
  epizootic levels in Asian domestic fowl

• Spread to wild bird populations across Europe and Africa, but no
  cases yet in US birds

• Human spread has been limited:

    – WHO reports 507 laboratory confirmed cases
    – 170 Indonesia, 119 Viet Nam, 112 Egypt, 39 China
    – 302 deaths for a 59.6% case fatality rate!


                     As of 18 October 2010, World Health Organization
     Transmissibility & NIOSH Research

• Transmissibility
  – Refers to ability of virus
    to pass from one person
    to another person


• Routes for Influenza
  – Large droplets
  – Small particle aerosols
  – Direct Contact


• What is the relative
  contribution of each?
  NIOSH Influenza Research
• Transmissibility Study
  – Droplet v. Aerosol Debate
  – Respirable aerosol sampler
  – Live virus laboratory analysis
     • Lab v. clinical studies


• N95 vs. Surgical Masks
  Effectiveness
  – Laboratory Tests
  – Large-scale clinical trial at VA
    facilities
 Aim 1: Measure airborne influenza virus in
           healthcare facilities
• Aerosol sampler developed at NIOSH                                   Filter
                                                                 particles < 1 mm
  Morgantown.                                                            Inlet
   – Separates particles by size.
• Aerosol sampling conducted at
  healthcare facilities.
   – Hospital emergency department.
   – Urgent Care walk-in clinic.
   – Two dental clinics.
• Stationary and personal aerosol                    2nd stage
  sampling were performed.                    (1.5 ml centrifuge tube)
                                                 particles 1 to 4 mm
• Aerosol samples were analyzed using
                                                      1st stage
  quantitative PCR.                            (15 ml centrifuge tube)
   – PCR detects the genetic material (RNA) of    particles > 4 mm
     the influenza virus.
   – PCR does not tell you if the virus is     NIOSH two-stage cyclone
     infectious.                                   aerosol sampler
                                                                                 25
  Aim 2: Determine how much influenza virus
        patients expel when they cough
          Patient         Ultrasonic
                          spirometer     Valve
                                                               Rolling
                                                                seal
                                                             spirometer


                               Aerosol
                               sampler




• A system was built to collect cough-generated aerosol particles.
• Patients were asked to seal their mouth around the mouthpiece and
  cough using as much of the air in their lungs as possible.
• Cough aerosol particles were then collected using an aerosol sampler.
                                                                          26
  Results of influenza cough aerosol study
                 unpublished
• Influenza RNA was detected in
  coughs from 38 of 47 influenza
  patients (81%).
• 65% of the influenza RNA was in
  the respirable size fraction.
• Viable influenza virus was cultured
  from the cough aerosols generated
  by 2 of 21 subjects with influenza.
   – Shows that at least some patients do
     cough out potentially infectious
     aerosols.
   – Better collection methods and more
     sensitive assays would likely increase   NIOSH cough aerosol particle
     this number.
                                                   collection system
• This work will continue during the
  next influenza season with a focus
  on the viability of the virus.
                                                                             27
   Aim 3: Simulate a healthcare worker
 exposed to a coughing infectious patient
     Simulated medical examination room contains:
      Cough aerosol simulator to represent a coughing patient.
       Breathing mannequin to simulate a healthcare worker.
         Aerosol particle counters to monitor particle spread.
     Aerosol samplers to collect virus for PCR or viability assays.
Breathing machine can be outfitted with different types of
             personal protective equipment.

                              6 ft
    Simulated                                     Simulated
    coughing                                      breathing
     patient                                      healthcare
                                                    worker
                                 Mask or
                                respirator



                                                                      28
    Particles inhaled while wearing no
   mask, surgical mask & N95 respirator
• Coughing and breathing
  systems were 6 feet apart                        10000
                                                                               No mask
  and facing each other.                            9000
                                                                               Surgical mask
• Plot shows concentration of                       8000                       N95 respirator
  aerosol particles at mouth
                                                    7000
  of breathing mannequin.


                                 Particles/liter
                                                    6000
• Surgical mask admitted
                                                    5000
  ~20% of particles.
• N95 respirator blocked                            4000

  virtually all particles.                          3000



                                                            cough
• Similar results are seen for                      2000
  other masks and                                   1000
  respirators and for all
                                                      0
  positions of the breathing                          -5       0       5       10     15     20
                                                           Time before/after cough (minutes)
  simulator.
                                                                                                  29
    Spread of particles in room after cough
•   Coughing and breathing systems were 6 feet apart and facing each other.
•   Breathing machine wearing N95 respirator and operating at 32 liters/minute.
•   Plot shows concentration of 0.3 to 0.4 mm KCl aerosol particles at different
    locations after a single cough.
                                                           15000
                                                                                        Near corner
                                                                                        Side
                                                                                        Far corner
Coughing                                                                                Outside mask
mannequin                 Breathing                        10000                        Inside mask
                          mannequin


                                         Particles/liter
                                                            5000



                                                                     cough
Dot color corresponds to line on graph                         0
                                                               -5      0       5        10     15     20
                                                                    Time before/after cough (minutes)
                                                                                                           30
        Simulated Examination Room:
                Future Work
                • Test different types of personal
                  protective equipment such as
                  PAPRs and face shields.
                • Measure the effects of room
                  ventilation.
                • Study the persistence and viability
                  of aerosols containing live
                  influenza virus under different
                  environmental conditions.




Cough aerosol                                           Breathing simulator
 simulator
                                                                              31
  Aim 4: Study generation of infectious
   aerosols during medical procedures
• Certain medical procedures may generate
  potentially infectious aerosols.
   – Bronchoscopy.
   – Suctioning.
   – Intubation.
• Data on the actual potential for disease
  transmission is very limited.
• Work is now underway to measure the
  amount and size of aerosol particles
  produced during medical procedures.            Bronchoscopy
                                                   Source: National
• In the future, will look at infectivity of        Cancer Institute
  aerosols.                                    http://visuals.nci.nih.gov/




                                                                        32
     Published Studies in Healthcare
                Facilities
• Airborne particles containing influenza
                                                              Aerosol
  virus RNA were found throughout the                         sampler
  Emergency Department and Urgent Care
  clinic during influenza season.
• Exposure levels were highest in                             Aerosol
  the locations and at the times                              sampler

  when the patient loads were
  heaviest.
    – On the busiest day at the Urgent Care                     Sampling
                                                                 pumps
      clinic, airborne influenza virus RNA
      was detected in every room.
• 42% to 53% of the influenza virus
  RNA was in respirable particles
  (< 4 µm).    Blachere et al, Clin Infect Dis 2009
                       Lindsley et al, Clin Infect Dis 2010
Method to Aerosolize Virus and Monitor Viability
                                     Calm Air Chamber                                      NIOSH Sampler
                                                                                  >1 mM particles

  Generate aerosolized
     viral particles




  Distribute aerosolized
     virus throughout
   Collection chamber                                                                 1-4 mM particles




  Collect viral particles                                                                                >4 mM particles
    In air samplers




                            Advantages of the Calm Air Chamber
                     •Simple cost-effective setup vs an Environmental Chamber
                         •Can evaluate the collection efficiency of samplers
                   •Can test multiple parameters for ability to maintain viability, i.e.
                        effect of humidity, temperature, aerosol particle size
                  •Can devise techniques to improve the preservation of viability of
                                             collected virus
Increasing the Sensitivity of Viral Detection
                                                        Flu
                                              Flu                  Flu


  Viral Plaque Assay                                                                 Viral Replication Assay

                                             Infect MDCK cells with virus


                                                                         •Isolate virus released from cells 20 h post-infection
                                                                                  •No waiting for plaque development




                                                                                           Isolate viral RNA


       Stain plaques
          & count                                                                   qPCR to amplify viral M gene

     Sensitivity                                                                            Sensitivity
      1-2 plaques                                                                      103-4   copies of M gene

     Timeframe                                                                          Timeframe
        6-8 days                                                                            2 days

                 Disadvantages                                                                   Disadvantages
    •Inefficient reinfection to form visible plaques                                   •Correlation with initial titer is unknown
       •Plaque size small and not well defined                                                      •More costly?
        •Plaques overlap-inaccurate counting
       2010 Updated CDC Guidance:
Prevention Strategies for Seasonal Influenza in
             Healthcare Settings
  • 75 Fed Reg 35,497 (22 June 2010)
     – Notice posted for public comment
     – Comment period (June 22 – July 22)
  • Content essentially similar to 2007 isolation precautions
    document (no N95 requirement as seen in 2009 Interim
    Guidance )
  • Airborne precautions are now extended to aerosol-
    generating procedures performed on patients with
    seasonal influenza
  • Final posted on 17 Sep 2010:
     – http://www.cdc.gov/flu/pdf/infectioncontrol_seasonalflu_ICU2010
       .pdf
    Mandatory CDC Guidance ?
• Should CDC’s voluntary infection control guidance for
  healthcare institutions be made mandatory?

  – OSHA Spring 2010 Regulatory Agenda
  – http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=201004&RIN
    =1218-AC46

  – Should OSHA rely solely on CDC Guidance for provisions of an
    Infectious Diseases Standard?


  – Cal/OSHA’s Aerosol Transmissible Diseases Standard
  – http://www.dir.ca.gov/Title8/5199.html
 Mandatory Influenza Vaccination for HCWs
• ID groups favor annual vaccination for HCW:
   –   Society for Healthcare Epidemiology of America (SHEA)
   –   Infectious Diseases Society of America (IDSA)
   –   American Academy of Pediatrics (AAP)
   –   American Public Health Association (APHA)?


• Position Papers General Argue:
   –   HCW vaccination is an important patient safety issue
   –   Voluntary approaches do not work, or at fail to get 100%
   –   HCW risk is small relative to patient risk of influenza
   –   Moral obligation for HCW to get vaccinated
        • Except for medical contraindications like vaccine allergy
   – Benefits outweigh any HCW concerns about coercion, impact on
     employer-employee relationship, and individual religious or personal
     belief objections.
  Mandatory Vaccination for HCWs

• Mandatory bargaining issue in 2009
  – Legal cases resulted in injunctions against
    unilateral employer actions to force
    vaccinations on HCWs (New York State).
• Religious and privacy issues
  – States regulate vaccination laws
  – Many states offer exemptions
     • Religious
     • Medical
     • Philosophical/Personal
          3. Genome v. Exposome

• Human Genome Project
  – Clinical tests
• New Laws
  – GINA
  – ADA Amendments Act

• Genetic Susceptibility
  – Health Standards
Exposome
       Genome and Exposome
Interactions in Disease Development



     Genome             Exposome


              Disease
                       Exposomics
• Study of the exposome
   – Measure of all the exposures of an individual in a lifetime and how those
     exposures relate to disease.
• Exposomics relies on other fields like genomics; metabonomics;
  lipidomics; transcriptomics and proteomics.

• Common threads of these fields are:
   – Use of biomarkers to determine exposure, effect of exposure,
     disease progression, and susceptibility factors;
   – Use of technologies that result in large amounts of data; and
   – Use of data mining techniques to find statistical associations
     between exposures, effect of exposures, and other factors such
     as genetics with disease.

• Exposomics could also potentially include the study of exposures in
  the environment that might improve or enhance health
                      Research Needs
• Develop and characterize biomarkers.

• Develop improved study tools and increased data sharing.

• Develop standardized criteria for study design and reporting.
    – A standardized manner for the collection and storage of data that incorporates
      information on epidemiology, genetics, biomarkers and exposure will allow for
      more holistic determination of exposure and improve our knowledge on the
      interaction of factors that lead to disease like the standardized approach for
      collection, analysis and dissemination of microarray data for genomics (called
      minimum-information-about-a-microarray-experiment (MIAME)).


• Improvement of all exposure assessment tools to comprehensively assess
  relationships among health outcomes and the many factors of exposure
  would aid in the knowledge about the insults in our environment, provide
  information concerning potential exposures, and provide an avenue for
  prevention.
                     4. WorkLife

• Hazards
  – Persistent
  – Emerging
• Employment
  – Flexible v. Precarious
  – Innovate v. Misclassify
  – Globally Competitive
• Workforce
  –   Age-Related Health
  –   Generational Attitudes
  –   OSH Challenges
  –   Social Benefits
  Occupational Safety & Health Act
                     29 U.S.C. 651(b)

• Congress declares it to be its purpose and policy
  – To assure as far as possible every working
    man and woman in the Nation safe and
    healthful working conditions and
  – To preserve our human resources--
     (5) By providing for research in the field of occupational safety
       and health, including the psychological factors involved, and
       by developing innovative methods, techniques, and
       approaches for dealing with occupational safety and health
       problems.
 Workforce Challenges



Limited availability
Chronologically gifted
Health-challenged Young Workers
         Growing Shortage of U.S. Workers
             Expected Labor Force and Labor Force Demand


250

200
Millions of People
150
                                                                                                                       Labor Needed
100
                                                                                                                       Labor Available
 50

  0
      2002
             2004
                    2006
                           2008
                                  2010
                                         2012
                                                2014
                                                       2016
                                                              2018
                                                                     2020
                                                                            2022
                                                                                   2024
                                                                                          2026
                                                                                                 2028
                                                                                                        2030
                                                                                          Source: Employment Policy Foundation analysis and
                                                                                                    projections of Census/BLS and BEA data.
       Dramatically Different Patterns of
               Growth by Age
        Percent Growth in U.S. Population by Age: 2000-2010

80%
                                        3. Rapid growth in the over-55 workforce

60%
                                                         48%

40%

                                             18%                          15%
20%
          5%          5%
 0%
        2. Few younger
-20%    workers entering         -9%

         16-24       25-34      35-44       45-54        55-64             65+

                                Age of Workers
                             1. Declining number of mid-career workers
                                                         Source: U.S. Census Bureau. 2000
        . . . Continuing Into the Future
       Percent Growth in U.S. Workforce by Age: 2000-2020

80%                                                   73%


60%                                                                54%


40%


20%
          7%        8%      7%
                                               3%
 0%

                                    -10%
-20%
        under 14   15-24   25-34    35-44     45-55   55-64         65+


                             Age of Workers
                                                        Source: U.S. Census Bureau
Health Challenged Young Workers
Childhood Obesity by Country
  Diabesity and the Future Workforce
• 39 States with 40% of young adults considered to be
  overweight or obese in just last decade!
   – In Kentucky, Alabama and Mississippi, >50% young
     adults are overweight
• Medical Consequences:
   –   High Blood Pressure
   –   High Fats in the Blood
   –   Type 2 Diabetes (formerly called adult-onset)
   –   Hepatic steatosis epidemic (fat deposits in the liver)
   –   Sleep apnea (too much fat around the upper airway)
• Psychological stress
• Musculoskeletal disorders
   – what the old and the young worker share
           Too Fat to Fight
• Military rejections:
  – Criminal record
  – Education deficiencies
  – Medical reasons
• Being overweight is now the leading
  cause for medical rejection
• Proportion of medical rejections has
  risen by 70% since 1995
Aging Productively
  Aging: A Balance of Factors

• Possible Limitations
  – Mental Capacity & Cognitive Limitations
  – Chronic Conditions
  – Physical Capacity
• Compensating Factors?
  –   Attitude
  –   Judgment
  –   Flexibility
  –   Interest in learning new things
Age and Chronic Conditions: How
   healthy are older workers?
  Aging Workforce: Social Policy Stress
• Social Security
   – In 1935, average life span at birth was 62
   – So, retirement benefits started at 65!
   – In 2010, figure has risen to 78.4 years and growing
   – Impact on Federal deficit
• Nations are banning early retirement and raising age
   – Greece @ 55 years
      • Plans to raise age to 63 and ban early retirement altogether
      • Riots ensued throughout Greece
   – France
      • Raised age from 60 to 62 by 2018 and country was paralyzed
        by strikes
   – Disadvantages workers in physically demanding jobs?
               Mental Retirement
• “Use it or lose I” (popular and scholarly literature)

   – Stave off normal cognitive aging or dementia by engaging in
     cognitively demanding activities
   – Converse: Un-demanding environment may fail to impede or even
     accelerate the process of cognitive decline

• Hypothesis that people can maintain their cognitive abilities
  through mental exercise is not proven, but suggestive

• 2010 Journal of Economic Perspectives’ paper addresses
  the question of whether retirement leads to cognitive decline
   – Uses cross-national comparable surveys of older persons from US,
     UK and eleven EU countries in 2004
   – Rohwedder & Willis, Journal of Econ Perspectives 24(1):119 (2010)
Mental Retirement
 Employee Wellness Practices: What’s the
              Evidence?

• Evidence:
  – More than opinion, anecdote or testimonial


• “…Growing body of empirical evidence*
  – Large proportion of diseases are preventable (risks are modifiable)
  – Risk-dependent diseases are costly & reduce worker productivity
    within short time window
  – Targeting risk behaviors can decrease costs and increase
    productivity
  – Worksite health promotion and disease prevention programs save
    companies money and produce + ROI
      * Goetzel & Reuters, Value in Health Care , Institute of Medicine (2010)
 CDC COMMUNITY GUIDE TO PREVENTIVE
SERVICES REVIEW – AJPM, FEBRUARY 2010




                 66
 SUMMARY RESULTS AND TEAM CONSENSUS


                      Body of    Consistent   Magnitude of
          Outcome     Evidence    Results        Effect       Finding
       Alcohol Use       9            Yes     Variable       Sufficient
Fruits & Vegetables      9            No      0.09 serving   Insufficient
       % Fat Intake     13            Yes     -5.4%           Strong
% Change in Those       18            Yes     +15.3 pct pt   Sufficient
  Physically Active
      Tobacco Use                                             Strong
        Prevalence      23            Yes     –2.3 pct pt
                        11
         Cessation                    Yes      +3.8 pct pt
 Seat Belt Non-Use      10            Yes     –27.6 pct pt   Sufficient



                                 67
       Centers for Total Worker Health
• University of Iowa Healthier Workforce Center for Excellence
   – http://www.public-health.uiowa.edu/hwce/

• Center for the Promotion of Health in the New England
  Workplace
   – At the University of Massachusetts
      http://www.uml.edu/centers/cph-new/
   – At the University of Connecticut
     http://www.oehc.uchc.edu/healthywork/index.asp

• Harvard School of Public Health Center for Work, Health and
  Wellbeing
   – http://centerforworkhealth.sph.harvard.edu/

• Veterans’ Administration , OPM & OMB
  Integrating Promotion & Protection
• Workers’ (modifiable) disease risks increased by
  exposure to occupational risks

• Workers at highest risk of work hazards are more
  likely to engage in (modifiable) health risks

• Workers at highest risk of work hazards are more
  likely to live in higher risk communities

• For workers’ at highest risk, integrating protection
  and promotion increases participation and program
  effectiveness
    4 Total Worker Health Examples
• Respiratory protection programs
   • That address cessation of tobacco use


• Ergonomics programs:
   • That address joint health and arthritis management


• Stress management programs:
   • That address workplace stressors, first, personal stressors second,
     then build worker resiliency


• Integration of clinics, behavioral health, traditional safety,
  health promotion, mentoring, EAP, nutrition, disability and
  workers’ compensation programs
Thank You for Your Attention!

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:6
posted:7/26/2011
language:English
pages:71
jizhen1947 jizhen1947
About Thosedocs come from internet,if you have the copyrights of one of them,tell me by mail zhenweda@163.com,and i will delete it on the first time Thank you!